Innocenti F, Yazdani A, Rashid N, Qu X, et al. Tumor immunogenomic features determine outcomes in metastatic colorectal cancer patients treated with standard-of-care combinations of bevacizumab and cetuximab. Clin Cancer Res 2022 Feb 17. pii: 681557. doi: 10.1158/1078-0432.CCR-21-3202.
PMID: 35176136